In this episode, Matt Wolf, Healthcare Senior Analyst at RSM, breaks down the latest market trends, including declining equity values, IPO delays, and the increasing reliance on private capital.

In this episode, Scott Becker covers three key market stories, including Oscar Health and RH stock drops, before discussing his updated Elon Musk scorecard.

In this episode, Scott Becker discusses the results of a Twitter poll on government spending, where 78% of respondents favored reductions. He also gives special shoutouts to standout business leaders and investment funds making an impact.

In this episode, Scott Becker breaks down eight key stories impacting markets, including government shutdown risks, shifting investor strategies, private equity trends, and major corporate moves from Intel and Starbucks.

In this episode, Scott Becker answers four reader questions, covering the impact of private equity on GI practices, the effects of health system consolidation on costs, how healthcare leaders can navigate a potential recession, and the role of physical therapy as a strategic service.

In this episode, Scott Becker discusses the looming government shutdown, the complexities of trade wars and tariffs, and the debate around deficit spending.

In this episode, Scott Becker breaks down the latest Elon Musk scorecard, grading Tesla’s performance, X’s progress, SpaceX’s innovations, and even Musk’s contributions to population growth.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, joins Scott Becker to discuss how tariffs and economic uncertainty are reshaping the deal-making landscape.

In this episode, Scott Becker discusses the latest inflation data and its mixed impact on the markets.

In this episode, Scott Becker shares a lighthearted take on retail shopping.